RxDoctor Payments Data

Michael Mackey, MD

Nephrology · Jonesboro, ARNPI 1437127800

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,003 of the $1,185 with a category attached, or 84.7%. 22 manufacturers reported payments, led by Bayer at 29.0% of the total. Reporting peaked in 2023 at $594 and has fallen 90.8% since, to $55 in 2025. That places this record below the midpoint for nephrology clinicians in AR, where the typical reported total is $925.

$1,185in general payments, 2019–2025

Across 50 payments — averaging $23.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$343
  • Otsuka America Pharmaceutical, Inc.$147
  • Abbott$124
  • Cordis US CORP.$59
  • Amgen$56
  • AstraZeneca$56
  • plus $400 from 16 others

What the payments were for

  • Food & beverage$1,00385%
  • Education$18115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,185 in reported general payments places this provider in the 50th percentile of 85 nephrology providers in Arkansas.

See all nephrology providers in Arkansas

Medicare billing

Part B allowed, 2024
$102,308
Medicare patients
144
Services billed
1,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole47$446
Febuxostat12$438
Fludrocortisone Acetate19$379
Furosemide92$371
Tamsulosin Hcl16$315
Potassium Chloride12$235
Pantoprazole Sodium24$194
Prednisone48$184
Labetalol Hcl12$174
Calcitriol22$136
LoperamideLoperamide Hcl11$128
Clonidine Hcl30$113
Amlodipine Besylate24$95
Allopurinol16$86
Torsemide12$77

Paid to pharmacies, not to this prescriber.

Other nephrology in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →